Cardlytics (NASDAQ:CDLX) CEO Amit Gupta Sells 6,676 Shares of Stock

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) CEO Amit Gupta sold 6,676 shares of Cardlytics stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $4.03, for a total transaction of $26,904.28. Following the transaction, the chief executive officer directly owned 125,389 shares in the company, valued at $505,317.67. This trade represents a 5.06% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Amit Gupta also recently made the following trade(s):

  • On Monday, August 17th, Amit Gupta sold 6,785 shares of Cardlytics stock. The shares were sold at an average price of $3.97, for a total value of $26,936.45.
  • On Monday, July 6th, Amit Gupta sold 9,640 shares of Cardlytics stock. The shares were sold at an average price of $4.39, for a total value of $42,319.60.
  • On Thursday, July 2nd, Amit Gupta sold 6,498 shares of Cardlytics stock. The shares were sold at an average price of $4.39, for a total transaction of $28,526.22.

Cardlytics Stock Performance

Shares of CDLX stock opened at $4.12 on Wednesday. The firm’s 50 day moving average price is $4.36 and its 200-day moving average price is $6.99. Cardlytics, Inc. has a one year low of $3.49 and a one year high of $32.80. The firm has a market cap of $23.94 million, a P/E ratio of -0.22 and a beta of 0.62.

Cardlytics (NASDAQ:CDLXGet Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The company reported ($1.50) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.30) by $0.80. The firm had revenue of $36.88 million for the quarter, compared to the consensus estimate of $37.00 million. Cardlytics had a negative return on equity of 956.56% and a negative net margin of 55.92%. As a group, research analysts predict that Cardlytics, Inc. will post -3.89 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on CDLX. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Cardlytics in a report on Wednesday, July 8th. Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a report on Thursday, June 18th. Lake Street Capital set a $10.00 price objective on shares of Cardlytics in a report on Friday, May 8th. Finally, Wall Street Zen upgraded Cardlytics from a “sell” rating to a “hold” rating in a research report on Saturday, August 8th. One equities research analyst has rated the stock with a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Sell” and an average price target of $10.00.

Read Our Latest Stock Analysis on Cardlytics

Institutional Investors Weigh In On Cardlytics

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Virtu Financial LLC purchased a new stake in Cardlytics in the 4th quarter valued at about $39,000. Qube Research & Technologies Ltd purchased a new position in shares of Cardlytics in the 3rd quarter valued at $55,000. Marshall Wace LLP purchased a new position in Cardlytics in the second quarter valued at about $59,000. Renaissance Technologies LLC acquired a new position in Cardlytics during the 4th quarter worth approximately $62,000. Finally, Barclays PLC lifted its position in shares of Cardlytics by 31,167.6% during the fourth quarter. Barclays PLC now owns 55,969 shares of the company’s stock worth $64,000 after purchasing an additional 55,790 shares in the last quarter. Hedge funds and other institutional investors own 68.10% of the company’s stock.

About Cardlytics

(Get Free Report)

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.

Featured Articles

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.